OPR - Delayed Quote • USD PYXS Jul 2024 7.500 call (PYXS240719C00007500) Follow 0.4000 0.0000 (0.00%) As of April 22 at 1:58 PM EDT. Market Open. Comparisons Indicators Technicals Corporate Events Chart Types Aggregated Types Draw Table View List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Date Close Open High Low Volume O H L C Vol AAPL Loading Chart for PYXS240719C00007500 1D 5D 1M 3M 6M YTD 1Y 2Y 5Y All Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours Recent News: PYXS Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Pyxis Oncology Obtains $8 Million Payment for the Sale of Royalty Rights Pyxis Oncology Inc (PYXS) Reports Encouraging Clinical Progress Amid Financial Challenges Pyxis Oncology Provides Corporate Update and Reports Financial Results for Fourth Quarter and Full Year 2023 Pyxis Oncology Expands Board of Directors with Appointment of Santhosh Palani, Ph.D., CFA Pyxis Oncology to Present at Leerink Global Biopharma Conference 2024 Pyxis Oncology to Present New PYX-201, PYX-106 and PYX-102 Preclinical Data at AACR Annual Meeting Pyxis Oncology Announces $50 Million Private Placement Pyxis Oncology Announces Appointment of Ken Kobayashi, M.D., F.A.C.P as Chief Medical Officer Pyxis Oncology Announces Initiatives to Prioritize Lead ADC Program; Reports Financial Results for Third-Quarter 2023 and Provides Corporate Update Pyxis Oncology Announces Four Abstracts Accepted for Poster Presentation at Society for Immunotherapy of Cancer (SITC) 2023 Insider Sell: President and CEO Lara Sullivan Sells 27,917 Shares of Pyxis Oncology Inc
